Publication Details
Publisher: BioScience Academic Publishing
Issue: Vol 3, No 11 (2026)
ISSN: 2997-7185

Abstract

The activity against microbes of Streptomyces azureus metabolites and green-synthesized copper oxide nanoparticles (CuO-NPs) against multidrug-resistant (MDR) bacteria was evaluated in the present study. In the synthesis of CuO-NPs, an aqueous extract of Camellia sinensis leaves, was used as a reducing and capping agent. UV–Vis, FTIR, SEM, and AFM examination substantiated the creation of stable, spherical nanoparticles with an average size of 70 nm. Streptomyces azureus (TA12), using 16S rRNA sequencing, was determined in a strong isolate from sediments of Iraqi soil. Various antibacterial compounds, such as 1-iodo-, Tetradecane, and Azetidine derivatives, were identified using GC-MS analysis. The minimum inhibitory concentration (MIC) of CuO-NPs against Escherichia coli and Staphylococcus aureus was 54.6 µg/m. CuO-NPs showed a potent activity against S. aureus (20 mm inhibition zone) but fragile activity against E. coli (10 mm). Equally, the S. azureus extract showed broad-spectrum antibacterial activity, producing inhibition zones of 17 mm against both pathogens. Correspondingly, the combination of CuO-NPs and Streptomyces azureus extract revealed an improved antimicrobial activity against both S. aureus and E. coli, producing inhibition zones of 24 and 20 mm, suggesting a synergetic interaction and demonstrating its potential for combating MDR bacterial pathogens.

Keywords
nanomaterials Streptomyces Nanobiotechnology MDR Bioactive metabolites